Cargando…

A Meta-Analysis of α-Synuclein Multiplication in Familial Parkinsonism

Chronic alpha-synuclein (SNCA) overexpression is a relatively homogenous and well-defined cause of parkinsonism and dementia. Parkinson's disease (PD), PD with dementia, dementia with Lewy bodies and multiple system atrophy all manifest in SNCA multiplication families. Herein we summarize genea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Book, Adam, Guella, Ilaria, Candido, Tara, Brice, Alexis, Hattori, Nobutaka, Jeon, Beomseok, Farrer, Matthew J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6297377/ https://www.ncbi.nlm.nih.gov/pubmed/30619023 http://dx.doi.org/10.3389/fneur.2018.01021

Ejemplares similares

Editorial: Targeting α-Synuclein in Parkinson's Disease and Multiple System Atrophy
por: Fellner, Lisa, et al.
Publicado: (2022)

Differential Diagnosis of Multiple System Atrophy-Parkinsonism and Parkinson's Disease Using α-Synuclein and External Anal Sphincter Electromyography
por: Cao, Zhentang, et al.
Publicado: (2020)

Editorial: Celebrating the Diversity of Genetic Research to Dissect the Pathogenesis of Parkinson's Disease
por: Farrer, Matthew J., et al.
Publicado: (2021)

Lipids: Key Players That Modulate α-Synuclein Toxicity and Neurodegeneration in Parkinson’s Disease
por: Mori, Akio, et al.
Publicado: (2020)

Optimization of the Detection Method for Phosphorylated α-Synuclein in Parkinson Disease by Skin Biopsy
por: Liu, Xiaojing, et al.
Publicado: (2020)

Targeting α-Synuclein in Parkinson's Disease by Induced Pluripotent Stem Cell Models
por: Spathopoulou, Angeliki, et al.
Publicado: (2022)

Diagnostic utility of CSF α-synuclein species in Parkinson's disease: protocol for a systematic review and meta-analysis
por: Eusebi, Paolo, et al.
Publicado: (2016)

Clinical Manifestations and Molecular Backgrounds of Parkinson's Disease Regarding Genes Identified From Familial and Population Studies
por: Nishioka, Kenya, et al.
Publicado: (2022)

Exposure of α-Synuclein Aggregates to Organotypic Slice Cultures Recapitulates Key Molecular Features of Parkinson's Disease
por: Moudio, Serge, et al.
Publicado: (2022)

A Systematic Review and Meta-Analysis of Alpha Synuclein Auto-Antibodies in Parkinson's Disease
por: Scott, Kirsten M., et al.
Publicado: (2018)

The Peripheral Inflammatory Response to Alpha-Synuclein and Endotoxin in Parkinson's Disease
por: White, Alice J., et al.
Publicado: (2018)

Alpha-Synuclein Targeting Therapeutics for Parkinson's Disease and Related Synucleinopathies
por: Menon, Sindhu, et al.
Publicado: (2022)

Plasma and Serum Alpha-Synuclein as a Biomarker of Diagnosis in Patients With Parkinson's Disease
por: Chang, Chun-Wei, et al.
Publicado: (2020)

α‐Synuclein V15A Variant in Familial Parkinson's Disease Exhibits a Weaker Lipid‐Binding Property
por: Daida, Kensuke, et al.
Publicado: (2022)

The mortality of patients with Parkinson's disease with deep brain stimulation
por: Kim, Ahro, et al.
Publicado: (2023)

Dermal Phospho-Alpha-Synuclein Deposition in Patients With Parkinson's Disease and Mutation of the Glucocerebrosidase Gene
por: Doppler, Kathrin, et al.
Publicado: (2018)

Erythrocytic alpha-synuclein as potential biomarker for the differentiation between essential tremor and Parkinson’s disease
por: Yu, Zhenwei, et al.
Publicado: (2023)

Identification of Disease-Associated Variants by Targeted Gene Panel Resequencing in Parkinson's Disease
por: Daida, Kensuke, et al.
Publicado: (2020)

Modulation of the Interactions Between α-Synuclein and Lipid Membranes by Post-translational Modifications
por: Bell, Rosie, et al.
Publicado: (2021)

The Effects of Safinamide Adjunct Therapy on Depression and Apathy in Patients With Parkinson's Disease: Post-hoc Analysis of a Japanese Phase 2/3 Study
por: Hattori, Nobutaka, et al.
Publicado: (2022)

The Concept of α-Synuclein Strains and How Different Conformations May Explain Distinct Neurodegenerative Disorders
por: Malfertheiner, Katja, et al.
Publicado: (2021)

The Quest for Anti-α-Synuclein Antibody Specificity—Lessons Learnt From Flow Cytometry Analysis
por: Leupold, Lukas, et al.
Publicado: (2022)

Expression profiles of α-synuclein in cortical lesions of patients with FCD IIb and TSC, and FCD rats
por: Zhang, Li, et al.
Publicado: (2023)

In vivo distribution of α-synuclein in multiple tissues and biofluids in Parkinson disease
por: Chahine, Lana M., et al.
Publicado: (2020)

α-Synuclein inclusions in the skin of Parkinson's disease and parkinsonism
por: Rodríguez-Leyva, Ildefonso, et al.
Publicado: (2014)

Longitudinal Alterations of Alpha-Synuclein, Amyloid Beta, Total, and Phosphorylated Tau in Cerebrospinal Fluid and Correlations Between Their Changes in Parkinson's Disease
por: Dolatshahi, Mahsa, et al.
Publicado: (2018)

Hunting for Familial Parkinson’s Disease Mutations in the Post Genome Era
por: Bentley, Steven R., et al.
Publicado: (2021)

Clinical Variability of SYNJ1-Associated Early-Onset Parkinsonism
por: Lesage, Suzanne, et al.
Publicado: (2021)

Commentary: Discriminating α-synuclein strains in parkinson's disease and multiple system atrophy
por: Fellner, Lisa, et al.
Publicado: (2020)

Salivary total α-synuclein, oligomeric α-synuclein and SNCA variants in Parkinson’s disease patients
por: Kang, Wenyan, et al.
Publicado: (2016)

Ablating Tau Reduces Hyperexcitability and Moderates Electroencephalographic Slowing in Transgenic Mice Expressing A53T Human α-Synuclein
por: Peters, Samuel T., et al.
Publicado: (2020)

α - synuclein and Parkinson’s disease: the first roadblock
por: Lin Chua, Christelle En, et al.
Publicado: (2006)

Immunological features of α-synuclein in Parkinson's disease
por: Roodveldt, Cintia, et al.
Publicado: (2008)

Models of α-synuclein aggregation in Parkinson’s disease
por: Giráldez-Pérez, Rosa María, et al.
Publicado: (2014)

Role of Apolipoproteins and α-Synuclein in Parkinson’s Disease
por: Emamzadeh, Fatemeh Nouri
Publicado: (2017)

The Role of α-Synuclein Oligomers in Parkinson’s Disease
por: Du, Xiao-yu, et al.
Publicado: (2020)

Biomarkers and the Role of α-Synuclein in Parkinson’s Disease
por: Du, Tingting, et al.
Publicado: (2021)

Olfactory Dysfunction in Familial and Sporadic Parkinson's Disease
por: Chase, Bruce A., et al.
Publicado: (2020)

Amelioration of pathologic α-synuclein-induced Parkinson’s disease by irisin
por: Kam, Tae-In, et al.
Publicado: (2022)

Young-onset parkinsonism due to homozygous duplication of α-synuclein in a consanguineous family
por: Kojovic, Maja, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_g74pfatmubqf0q4qim6uv0h30c